- Home
- NNNN vs MSIF Comparison
NNNN vs MSIF Comparison
Compare NNNN & MSIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- MSIF
- Stock Information
- Founded
- NNNN 2021
- MSIF 2011
- Country
- NNNN Germany
- MSIF United States
- Employees
- NNNN N/A
- MSIF N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MSIF
- Sector
- NNNN Health Care
- MSIF
- Exchange
- NNNN Nasdaq
- MSIF NYSE
- Market Cap
- NNNN 267.7M
- MSIF 720.1M
- IPO Year
- NNNN 2025
- MSIF N/A
- Fundamental
- Price
- NNNN $6.63
- MSIF $15.58
- Analyst Decision
- NNNN
- MSIF Buy
- Analyst Count
- NNNN 0
- MSIF 5
- Target Price
- NNNN N/A
- MSIF $18.50
- AVG Volume (30 Days)
- NNNN 32.8K
- MSIF 40.5K
- Earning Date
- NNNN 01-01-0001
- MSIF 01-01-0001
- Dividend Yield
- NNNN N/A
- MSIF 2.32%
- EPS Growth
- NNNN N/A
- MSIF N/A
- EPS
- NNNN 0.06
- MSIF 1.41
- Revenue
- NNNN $8,185,146.00
- MSIF $134,828,000.00
- Revenue This Year
- NNNN N/A
- MSIF $11.88
- Revenue Next Year
- NNNN N/A
- MSIF $12.55
- P/E Ratio
- NNNN $116.38
- MSIF $11.03
- Revenue Growth
- NNNN 21.95
- MSIF 2.62
- 52 Week Low
- NNNN $5.18
- MSIF $14.01
- 52 Week High
- NNNN $7.82
- MSIF $18.00
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- MSIF N/A
- Support Level
- NNNN N/A
- MSIF N/A
- Resistance Level
- NNNN N/A
- MSIF N/A
- Average True Range (ATR)
- NNNN 0.00
- MSIF 0.00
- MACD
- NNNN 0.00
- MSIF 0.00
- Stochastic Oscillator
- NNNN 0.00
- MSIF 0.00
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About MSIF MSC INCOME FUND INC
MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.